Rapid Evacuation and Access of Cerebral Hemorrhage Registry

Part of paid clinical trials in Atlanta, Georgia.

Sponsor
Emory University
Study ID
NCT07651631
Status
Recruiting
Apply to this trial

Conditions

  • Intracerebral Hemorrhage

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The goal of this observational study is to quantify the real-world effect of minimally invasive surgery (MIS) in patients with acute spontaneous supratentorial intracerebral hemorrhage.

Key Dates

First listed
Jun 16, 2026
Start date
Aug 12, 2026
Status verified
Aug 2026
Primary completion
Jun 30, 2033
Completion
Jun 30, 2033

Study Design

Enrollment
2,500 participants (estimated)

Arms

  • Arm: Minimally Invasive Surgical Groups
    * Surgical A: Endport evacuation (i.e., MIPS via BrainPath or similar device) * Surgical B: Endoscopic evacuation * Surgical C: Catheter-based evacuation * Surgical D: Other minimally invasive surgical techniques involving clot evacuation
  • Arm: Control Group
    No minimally invasive surgical hematoma evacuation performed; n=300 total, capped across 20 sites; may include patients undergoing decompressive hemicraniectomy or other standard medical/surgical approaches): * Basal Ganglia Controls (\>50% IVH or ICH volume ≥80 mL; n=100) * Lobar Controls (ICH volume ≥80 mL; n=100) * Primary Thalamic Controls (n=100) * ENRICH Trial Controls (ABG and lobar locations; n=150) * REACH Trial Controls (ABG location; n=maximum 300)

Primary Outcome Measure

Modified Rankin Scale (mRS) at 180 Days [ Time Frame: Day 180 from baseline (±14 days) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Grady Memorial HospitalAtlantaGeorgia30303
Alex Hall, DHSc, MS
Alex Hall, DHSc, MS (PRINCIPAL_INVESTIGATOR)
Jonathan Ratcliff, MD, MPH (PRINCIPAL_INVESTIGATOR)

Find similar trials in Atlanta, GA

By research site
Grady Memorial Hospital· Atlanta, GA

Related Studies